CVE-2020-5821
Symantec Endpoint Protection (SEP) and Symantec Endpoint Protection Small Business Edition (SEP SBE), prior to 14.2 RU2 MP1 and prior to 14.2.5569.2100 respectively, may be susceptible to a DLL injection vulnerability, which is a type of issue whereby…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.43%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Symantec Endpoint Protection (SEP) and Symantec Endpoint Protection Small Business Edition (SEP SBE), prior to 14.2 RU2 MP1 and prior to 14.2.5569.2100 respectively, may be susceptible to a DLL injection vulnerability, which is a type of issue whereby an individual attempts to execute their own code in place of legitimate code as a means to perform an exploit.
- CVSS 3.1
- 7.8 HIGHCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.43% probability · 36th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-427
- Affected
- symantec/endpoint protection
- Source
- secure@symantec.com
References
- https://support.symantec.com/us/en/article.SYMSA1505.htmlVendor Advisory
- https://support.symantec.com/us/en/article.SYMSA1505.htmlVendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.